Autophagy–Gut Microbiota–Epigenetic Interactions in Disease Pathogenesis: Focus on Neurodegenerative and Neuropsychiatric Disorders and Therapeutic Perspectives
5 affiliations
- 1Department of Animal Science, Faculty of Science, University of Mazandaran, Babolsar 47416-13534, Iran
- 2Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 14496-14535, Iran
- 3Lung Diseases Research Center, Ardabil University of Medical Sciences, Ardabil 85991-56189, Iran
- 4Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA
- 5Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Abstract
Autophagy is a key cellular process that participates in numerous physiological functions, including maintaining epithelial barrier integrity, regulating intracellular degradation pathways, modulating immune responses, and enhancing antimicrobial defense. Impaired autophagy may contribute to the accumulation of misfolded proteins and insoluble aggregates in the neuronal cytoplasm, defective clearance of damaged organelles and proteins, and the buildup of toxic metabolites. In the gut, these alterations may disrupt the balance between beneficial and potentially harmful microorganisms, contributing to gut dysbiosis, chronic inflammation, and epigenetic alterations in intestinal cells that may indirectly affect the brain. Here, we review the current evidence on the interplay among autophagy, the gut microbiota, and the epigenome in the pathogenesis of diseases, particularly neuropsychiatric disorders (NPDs) and neurodegenerative diseases (NDs). First, we briefly discuss autophagy and its roles in health and disease. We then examine the association between impaired autophagy, inflammation, and epigenetic aberrations in the pathogenesis of NPDs and NDs. Next, we focus on the relationships among gut dysbiosis, defective autophagy, and epigenetic alterations in NPDs and NDs, and discuss microbiota-based therapeutic strategies that may influence epigenetic regulation and autophagic function. Finally, we highlight the current challenges and future directions for investigating the critical role of these interactions in the pathogenesis and treatment of NPDs and NDs.
Related
- Ferroptosis and Cuproptosis in the Pathogenesis of Breast Cancer: Molecular Mechanisms, Crosstalk, and Therapeutic Perspectives
- From microbial dysbiosis to putative epigenetic locking: a hypothesis-driven framework for the pathogenesis and future therapeutic perspectives of gastric intestinal metaplasia.
- MicroRNAs in Neurodevelopment and Their Relationship with Neurological, Neuropsychiatric and Neurodegenerative Diseases
- Effectiveness, safety and therapeutic potential of medical cannabis across treatment-resistant neuropsychiatric disorders: systematic review and meta-analysis
- Therapeutic Reversal of Severe Neuropsychiatric Symptoms in Wilson's Disease: A Case Report.
BibTeX
@article{mashayekhpour2026autophagygut,
title = {{Autophagy–Gut Microbiota–Epigenetic Interactions in Disease Pathogenesis: Focus on Neurodegenerative and Neuropsychiatric Disorders and Therapeutic Perspectives}},
author = {Mohammad Amin Mashayekhpour and Hamed Amani and Ali Akbar Hajizadeh Hajizadeh Moghaddam and Alireza Moradi and Shabnam Nohesara and Hamid Mostafavi Abdolmaleky},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219502},
url = {https://www.mdpi.com/1422-0067/27/21/9502},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Autophagy–Gut Microbiota–Epigenetic Interactions in Disease Pathogenesis: Focus on Neurodegenerative and Neuropsychiatric Disorders and Therapeutic Perspectives
AU - Mohammad Amin Mashayekhpour
AU - Hamed Amani
AU - Ali Akbar Hajizadeh Hajizadeh Moghaddam
AU - Alireza Moradi
AU - Shabnam Nohesara
AU - Hamid Mostafavi Abdolmaleky
PY - 2026
DA - 2026/10/24
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219502
UR - https://www.mdpi.com/1422-0067/27/21/9502
AB - Autophagy is a key cellular process that participates in numerous physiological functions, including maintaining epithelial barrier integrity, regulating intracellular degradation pathways, modulating immune responses, and enhancing antimicrobial defense. Impaired autophagy may contribute to the accumulation of misfolded proteins and insoluble aggregates in the neuronal cytoplasm, defective clearance of damaged organelles and proteins, and the buildup of toxic metabolites. In the gut, these alterations may disrupt the balance between beneficial and potentially harmful microorganisms, contributing to gut dysbiosis, chronic inflammation, and epigenetic alterations in intestinal cells that may indirectly affect the brain. Here, we review the current evidence on the interplay among autophagy, the gut microbiota, and the epigenome in the pathogenesis of diseases, particularly neuropsychiatric disorders (NPDs) and neurodegenerative diseases (NDs). First, we briefly discuss autophagy and its roles in health and disease. We then examine the association between impaired autophagy, inflammation, and epigenetic aberrations in the pathogenesis of NPDs and NDs. Next, we focus on the relationships among gut dysbiosis, defective autophagy, and epigenetic alterations in NPDs and NDs, and discuss microbiota-based therapeutic strategies that may influence epigenetic regulation and autophagic function. Finally, we highlight the current challenges and future directions for investigating the critical role of these interactions in the pathogenesis and treatment of NPDs and NDs.
SN - 1422-0067
ER -